Novartis | Driftskostnader

Operating Expenses Endring Dato
AbbVie USD 11.11B 540M 2023-12
Alcon AG USD 2.04B 116M 2023-09
Almirall EUR 427.18M 375K 2023-06
Amgen USD 6.93B 2.11B 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Bayer EUR 13.94B 1.94B 2023-09
Eli Lilly USD 6.97B 2.08B 2023-12
Galapagos EUR 166.58M 9.54M 2023-09
Genmab DKK 3.03B 326M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
GRIFOLS EUR 1.51B 167.87M 2023-12
Hikma Pharmaceutical USD 1.18B 60M 2023-06
Lonza CHF 2.54B 193M 2023-06
Pfizer USD 20.8B 4.62B 2023-12
Philips EUR 4.25B 2M 2023-09
Recordati EUR 385.72M 33.73M 2023-09
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
UCB EUR 2.11B 388M 2023-06



Novartis Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.